| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06609304 | Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large… | Lymphoma, B-Cell | Recruiting |
| NCT06956092 | Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma | B Cell Lymphoma (BCL) | Not Yet Recruiting |
| NCT07046182 | Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of… | Angioimmunoblastic T-cell Lymphoma (AITL) | Active, Not Recruiting |
| NCT07264894 | ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a… | Mantle Cell Lymphoma (MCL) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07117305 | CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation | CD7+ Lymphoma | Not Yet Recruiting |
| Not specified | |||
| NCT05506410 | A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed… | Newly Diagnosed Mantle Cell Lymphoma | Recruiting |
| NCT06742879 | A Multi-center Clinical Study of Zanubrutinib in Combination With First-line… | Follicular Lymphoma | Active, Not Recruiting |
| NCT07198464 | Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell… | Primary Central Nervous System Lymphoma (PCNSL) | Not Yet Recruiting |
| NCT07299331 | Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone… | Marginal Zone Lymphoma(MZL) | Not Yet Recruiting |
| NCT07563335 | Stage-Matched Psychosocial Intervention for Parent Caregivers of Children With Leukemia… | Childhood Leukemia | Enrolling by Invitation |
| NCT07587411 | Stepped-Care Support for Children With Leukaemia | Childhood Leukemia | Enrolling by Invitation |